![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, May 10, 2019 11:50:49 AM
N ARBOR, Mich., – May 10, 2016 - Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, today announced the creation of four new lines of transgenic silkworms. These new transgenics are based on a new set of the Company’s most complex protein designs to date. These new designs are targeted for applications in performance apparel, medical, and ballistic protection, where their intended strength improvements should provide even higher levels of durability. The Company believes that these new transgenics have the potential to produce silk fibers with an unprecedented combination of physical properties with the potential to rival its existing Dragon SilkTM line. Over the next several months the Company will start testing each of these newly created transgenics to measure their performance and use for targeted application.
“These are the most complex genetic constructions that we have ever created in the Company’s history,” said COO Jon Rice. “In some cases, these designs took more than 12 months to perfect and we are just now able to confirm that this work has resulted in successful transgenics. This work represents a significant breakthrough in our efforts to bring transformative technical fibers to market and is a clear demonstration of our capability for continuous innovation.”
The Company expects to announce more details on the performance of these new materials over the coming months as performance testing is completed and each of these new transgenic silkworm lines obtain homozygosity.
If you can't explain it simply, you don't understand it well enough.
Albert Einstein
Recent KBLB News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 06/10/2024 08:30:30 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/04/2024 04:15:03 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM